NCT07388524 2026-04-17
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
National Cancer Institute (NCI)
Phase 3 Not yet recruiting
National Cancer Institute (NCI)
Medical University of South Carolina
Zhujiang Hospital
Mayo Clinic
Indiana University
Aura Biosciences
German CLL Study Group
M.D. Anderson Cancer Center
University of Vermont Medical Center
Shanghai Chest Hospital
University of Vermont Medical Center